Research theme for competitive and other funds (3)：
2022 - 2026 不顕性誤嚥の検出における唾液腺シンチグラフィーの応用
2019 - 2022 Development of an targeted radionuclide therapy of triple-negative breast cancer for clinical application
2016 - 2019 Development of a radioimmunotherapy (RIT) agent for triple-negative breast cancer
Papers (5)：
Hiromi Hirasawa, Ayako Taketomi-Takahashi, Natsumi Katsumata, Tetsuya Higuchi, Yoshitaka Sekine, Kazuhiro Suzuki, Yoriaki Kaneko, Keiju Hiromura, Yasuhiro Fukushima, Yoshito Tsushima. Efficacy of 18F-Fluorodeoxyglucose positron emission tomography/computed tomography for detecting renal cell carcinoma in patients with end-stage renal disease. Japanese journal of radiology. 2024
Koichi Yamaguchi, Takahito Nakajima, Aya Yamaguchi, Miki Itai, Yuji Onuki, Yuki Shin, Shogo Uno, Sohei Muto, Shunichi Kouno, Masakiyo Yatomi, et al. Quantitative CT analysis of interstitial pneumonia in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis: a single center, retrospective study. Clinical rheumatology. 2022. 41. 5. 1473-1481
Wenchao Gu, Ryan Yudistiro, Hirofumi Hanaoka, Natsumi Katsumata, Yoshito Tsushima. Potential of three-step pretargeting radioimmunotherapy using biotinylated bevacizumab and succinylated streptavidin in triple-negative breast cancer xenograft. Annals of nuclear medicine. 2021. 35. 4. 514-522
